A study in humans demonstrated that the miR-6776-3p was downregulated in whole blood of patients with recurrent myocardial infarction after percutaneous coronary intervention, with this differential expression remaining significant after false discovery rate correction (FDR <0.1) in a replication cohort [Onuoha et al. DOI:10.1111/cts.13307].